A catalase inhibitor: Targeting the NADPH-binding site for castration-resistant prostate cancer therapy.
Cao YY, Chen YY, Wang MS, Tong JJ, Xu M, Zhao C, Lin HY, Mei LC, Dong J, Zhang WL, Qin YX, Huang W, Zhang D, Yang GF.
Cao YY, et al. Among authors: huang w.
Redox Biol. 2023 Jul;63:102751. doi: 10.1016/j.redox.2023.102751. Epub 2023 May 16.
Redox Biol. 2023.
PMID: 37216701
Free PMC article.